𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A Phase II Trial of Pyrazine Diazohydroxide in Patients with Disseminated Malignant Melanoma and no Prior Chemotherapy – Southwest Oncology Group Study

✍ Scribed by Robert P. Whitehead; Joseph M. Unger; Lawrence E. Flaherty; Eric H. Kraut; Glenn M. Mills; Catherine E. Klein; Robert A. Chapman; Gary C. Doolittle; Neel Hammond; Vernon K. Sondak

Book ID
110329386
Publisher
Springer US
Year
2002
Tongue
English
Weight
78 KB
Volume
20
Category
Article
ISSN
0167-6997

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase II trial of vinorelbine tartrate
A Phase II trial of vinorelbine tartrate in patients with disseminated malignant melanoma and one prior systemic therapy : A Southwest Oncology Group study
✍ Robert P. Whitehead; James Moon; S. Spence McCachren; Evan M. Hersh; Wolfram E. 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 3 views

## Abstract ## BACKGROUND Single‐agent chemotherapy with dacarbazine continues to be the standard of care for the treatment of metastatic melanoma. However, there is a large population of patients who have failed first‐line therapy and might benefit from additional treatment. In the current study,

Combination chemotherapy plus BCG in the
Combination chemotherapy plus BCG in the treatment of disseminated malignant melanoma: A southwest oncology group study
✍ Costanzi, John J. ;Al-Sarraf, Muhyi ;Groppe, Carl ;Bottomley, Richard ;Fabian, C 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 466 KB

## Abstract The Southwest Oncology Group performed a randomized study comparing combination chemotherapy alone versus combination chemotherapy plus BCG versus DTIC plus BCG in the treatment of disseminated malignant melanoma. A 31% response rate was noted with combination chemotherapy alone, a 27%